Endoscopic Colorectal Cancer Screening: a Cost-Saving Analysis

Endoscopic colorectal cancer screening: a cost-saving analysis.

BACKGROUND Comprehensive analyses have shown that screening for cancer usually induces net costs. In this study, the possible costs and savings of endoscopic colorectal cancer screening are explored to investigate whether the induced savings may compensate for the costs of screening. METHODS A simulation model for evaluation of colorectal cancer screening, MISCAN-COLON, is used to predict cos...

Endoscopic colorectal cancer screening: a cost-saving analysis

Advanced endoscopic technologies for colorectal cancer screening.

Colorectal cancer is the third most common cancer in men and the second most common cancer in women worldwide. Diagnosing colorectal has been increasingly successful due to advances in technology. Flexible endoscopy is considered to be an effective method for early diagnosis and treatment of gastrointestinal cancer, making it a popular choice for screening programs. However, millions of people ...

Population based endoscopic screening for colorectal cancer

CASE FOR SCREENING There is no longer doubt that screening is an effective method of reducing colorectal cancer (CRC) incidence and mortality rates. The US Preventive Services Task Force recently reviewed the evidence and gave a grade A recommendation that all men and women over the age of 50 years should be screened for CRC. In the UK, the Department of Health has demonstrated its commitment t...

Screening for Colorectal Cancer: Analysis of Evidence and Cost-Effectiveness

Colorectal cancer causes significant morbidity and mortality and remains the second most common cause of cancer-related death in the United States. A number of screening approaches have been shown to decrease colon cancer–related mortality and are cost-effective. In this review, we discuss available screening approaches and suggest strategies to implement effective screening using the current t...